CT
DGX icon

Colonial Trust’s Quest Diagnostics DGX Stock Holding History

Colonial Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593K Sell
2,796
-100
-3% -$19.6K 0.08% 165
2026
Q1 		$568K Sell
2,896
-425
-13% -$82.6K 0.08% 174
2025
Q4 		$576K Sell
3,321
-417
-11% -$75.9K 0.08% 172
2025
Q3 		$712K Sell
3,738
-202
-5% -$35.8K 0.1% 152
2025
Q2 		$708K Sell
3,940
-94
-2% -$16.3K 0.1% 145
2025
Q1 		$683K Sell
4,034
-368
-8% -$60.5K 0.11% 138
2024
Q4 		$664K Buy
4,402
+433
+11% +$67.3K 0.1% 153
2024
Q3 		$616K Sell
3,969
-89
-2% -$13.3K 0.1% 160
2024
Q2 		$556K Sell
4,058
-322
-7% -$44.1K 0.1% 146
2024
Q1 		$583K Buy
4,380
+60
+1% +$7.79K 0.11% 136
2023
Q4 		$596K Sell
4,320
-829
-16% -$109K 0.12% 131
2023
Q3 		$627K Sell
5,149
-50
-1% -$6.66K 0.16% 116
2023
Q2 		$731K Sell
5,199
-25
-0.5% -$3.45K 0.18% 103
2023
Q1 		$739K Sell
5,224
-144
-3% -$20.6K 0.19% 99
2022
Q4 		$840K Buy
5,368
+225
+4% +$32.3K 0.23% 91
2022
Q3 		$631K Buy
+5,143
New +$677K 0.2% 104

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Colonial Trust's DGX Position: Q2 2026 in Review

Colonial Trust reduced its Quest Diagnostics (DGX) stake by 3.5% in Q2 2026, selling an estimated $19.6K and leaving 2,796 shares worth $593K. The position accounts for 0.08% of the portfolio, ranked #165.

Colonial Trust first reported a position in DGX in Q3 2022 and has held it in 16 quarters since. The position peaked at $840K in Q4 2022. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Colonial Trust held 2,796 shares of Quest Diagnostics worth $593K as of Q2 2026.
  • Colonial Trust sold 100 Quest Diagnostics shares in Q2 2026, an estimated $19.6K.
  • Quest Diagnostics made up 0.08% of Colonial Trust's portfolio in Q2 2026, its #165 holding.
  • Colonial Trust first reported a position in Quest Diagnostics in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's Quest Diagnostics position peaked at $840K in Q4 2022.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.